High frequency of somatic missense mutation of BRCA2 in female breast cancer from Taiwan

Cancer Letters

Volumn 220, Issue 2, 2005, Pages 177-184

  Chen, Fang Ming ^a,b,c   Hou, Ming Feng ^b   Chang, Mei Yin ^c   Wang, Jaw Yuan ^b,c   Hsieh, Jan Sing ^b   Ou Yang, Fu ^b   Huang, Tsung Jen ^b   Lin, Shiu Ru ^c  

^a KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

BRCA2; Breast cancer; Somatic mutation; Taiwan

Indexed keywords

BRCA2 PROTEIN; NUCLEOTIDE; RAD51 PROTEIN;

AGE; AMINO ACID SEQUENCE; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST DUCT; CANCER GRADING; CANCER INCIDENCE; CANCER SCREENING; CANCER SURGERY; CARCINOMA IN SITU; CHROMOSOME 13Q; CLINICAL FEATURE; CLINICAL TRIAL; CODON; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; EXON; FAMILY HISTORY; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENE LOCUS; GENETIC DATABASE; GENETIC SCREENING; HISTOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL ASSESSMENT; MISSENSE MUTATION; MUTATIONAL ANALYSIS; PATIENT SELECTION; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; SOMATIC MUTATION; TAIWAN;

EID: 17644411687     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.10.024     Document Type: Article

References (40)

1. R. Wooster, G. Bignell, J. Lancaster, S. Swift, S. Seal, and J. Mangion Identification of the breast cancer susceptibility gene BRCA2 Nature 378 1995 789 792
2. D. Ford, D.F. Easton, M. Stratton, S. Narod, D. Goldgar, and P. Devilee Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium Am. J. Hum. Genet. 62 1998 676 689
3. A.R. Venkitaraman Cancer susceptibility and the functions of BRCA1 and BRCA2 Cell 108 2002 171 182
4. S. Thorlacius, G. Olafsdottir, L. Tryggvadottir, S. Neuhausen, J.G. Jonasson, and S.V. Tavtigian A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes Nat. Genet. 13 1996 117 119
5. J. Gudmundsson, G. Johanesdottir, J.T. Bergthorsson, A. Arason, S. Ingvarsson, V. Egilsson, and R.B. Barkardottir Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13 Cancer Res. 55 1995 4830 4832
6. J.M. Lancaster, R. Wooster, J. Mangion, C.M. Phelan, C. Cochran, and C. Gumbs BRCA2 mutations in primary breast and ovarian cancers Nat. Genet. 13 1996 238 240
7. Y. Miki, T. Katagiri, F. Kasumi, T. Yoshimoto, and Y. Nakamura Mutation analysis in the BRCA2 gene in primary breast cancers Nat. Genet. 13 1996 245 247
8. D.H. Teng, R. Bogden, J. Mitchell, M. Baumgard, R. Bell, and S. Berry Low incidence of BRCA2 mutations in breast carcinoma and other cancers Nat. Genet. 13 1996 241 244
9. B.H. Weber, M. Brohm, I. Stec, J. Backe, and H. Caffier A somatic truncating mutation in BRCA2 in a sporadic breast tumor Am. J. Hum. Genet. 59 1996 962 964
10. J. van den Berg, O. Johannsson, S. Hakansson, H. Olsson, and A. Borg Allelic loss at chromosome 13q12-q13 is associated with poor prognosis in familial and sporadic breast cancer Br. J. Cancer 74 1996 1615 1619
11. R.K. Schmutzler, E. Bierhoff, T. Werkhausen, R. Fimmers, P. Speiser, and E. Kubista Genomic deletions in the BRCA1, BRCA2 and TP53 regions associate with low expression of the estrogen receptor in sporadic breast carcinoma Int. J. Cancer 74 1997 322 325
12. A. Hanby, D.P. Kelsell, H. Potts, C.E. Gillett, D.T. Bishop, N.K. Spurr, and D.M. Barnes Association between loss of heterozygosity of BRCA1 and BRCA2 and morphological attributes of sporadic breast cancer Int. J. Cancer 88 2000 204 208
13. A.G. Knudson Karnofsky Memorial Lecture. Hereditary cancer: theme and variations J. Clin. Oncol. 15 1997 3280 3287
14. D.M. Livingston EMSY, a BRCA-2 partner in crime Nat. Med. 10 2004 127 128
15. C.I. Szabo, A. Masiello, J.F. Ryan, and L.C. Brody The breast cancer information core: database design, structure and scope Hum. Mut. 16 2000 123 131
16. C.I. Szabo, and M.C. King Population genetics of BRCA1 and BRCA2 Am. J. Hum. Genet. 60 1997 1013 1020
17. A. Liede, and S.A. Narod Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2 Hum. Mutat. 20 2002 413 424
18. J.V. Lacey Jr., S.S. Devesa, and L.A. Brinton Recent trends in breast cancer incidence and mortality Environ. Mol. Mutagen. 30 2002 82 88
19. Epidemiology of the principal cancers, Department of Health, Taiwan, 1999.
20. Health Statistics, Department of Health, Taiwan, 2000.
21. F.M. Chen, M. Hou, J.Y. Wang, T.C. Chen, D.C. Chen, and S.Y. Huang High frequency of G/C transversion on p53 gene alterations in breast cancers from Taiwan Cancer Lett. 207 2004 59 67
22. S.S. Li, H.M. Tseng, T.P. Yang, C.H. Liu, S.J. Teng, and H.W. Huang Molecular characterization of germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in Taiwan Hum. Genet. 104 1999 201 204
23. A.K. Wong, R. Pero, P.A. Ormonde, S.V. Tavtigian, and P.L. Bartel RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2 J. Biol. Chem. 272 1997 31941 31944
24. L. Pellegrini, D.S. Yu, T. Lo, S. Anand, M. Lee, T.L. Blundell, and A.R. Venkitaraman Insights into DNA recombination from the structure of a RAD51-BRCA2 complex Nature 420 2002 287 293
25. K.B. Tsai, M.F. Hou, H.J. Lin, C.Y. Chai, C.S. Liu, and T.J. Huang Expression of HER-2/NEU oncoprotein in familial and non-familial breast cancer Kaohsiung J. Med. Sci. 17 2001 64 76
26. J. Sambrook E.F. Fritsch T. Maniatis Molecular Cloning. A Laboratory Manual second ed. 1989 Cold Spring Harbor Laboratory New York
27. J.T. Dunnen, and S.E. Antonarakis Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion Hum. Mutat. 15 2000 7 12
28. D. Prechtel, A.K. Werenskiold, K. Prechtel, G. Keller, and H. Hofler Frequent loss of heterozygosity at chromosome 13q12-13 with BRCA2 markers in sporadic male breast cancer Diag. Mol. Pathol. 7 1998 57 62
29. E. Kwiatkowska, M. Teresiak, D. Breborowicz, and A. Mackiewicz Somatic mutations in the BRCA2 gene and high frequency of allelic loss of BRCA2 in sporadic male breast cancer Int. J. Cancer 98 2002 943 945
30. A. Koul, M. Nilbert, and A. Borg A somatic BRCA2 mutation in RER_ endometrial carcinomas that specifically deletes the amino-terminal transactivation domain Genes Chrom. Cancer 24 1999 207 212
31. J.Y. Wang, J.S. Hsieh, F.M. Chen, C.S. Yeh, K. Alexandersen, and T.J. Huang High frequency of activated K-ras codon 15 mutant in colorectal carcinomas from Taiwanese patients Int. J. Cancer 107 2003 387 393
32. S.M. Johnson, J.A. Shaw, and R.A. Walker Sporadic breast cancer in young women: prevalence of loss of heterozygosity at p53, BRCA1 and BRCA2 Int. J. Cancer 98 2002 205 209
33. Breast Cancer Linkage Consortium Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases Lancet 349 1997 1505 1510
34. M.E. Robson, P.O. Chappuis, J. Satagopan, N. Wong, J. Boyd, and J.R. Goffin A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment Breast Cancer Res. 6 2004 R8 R17
35. B.B. Roa, A.A. Boyd, K. Volcik, and C.S. Richards Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2 Nat. Genet. 14 1996 185 187
36. N.D. Kauff, P. Perez-Segura, M.E. Robson, L. Scheuer, B. Siegel, and A. Schluger Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families J. Med. Genet. 39 2002 611 614
37. J. Chang-Claude, J. Dong, S. Schmidt, M. Shayeghi, D. Komitowski, and H. Becher Using gene carrier probability to select high risk families for identifying germline mutations in breast cancer susceptibility genes J. Med. Genet. 35 1998 116 121
38. G. Parmigiani, D. Berry, and O. Aguilar Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2 Am. J. Hum. Genet. 62 1998 145 158
39. T.S. Frank, S.A. Manley, O.I. Olopade, S. Cummings, J.E. Garber, and B. Bernhardt Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk J. Clin. Oncol. 16 1998 2417 2425
40. L. Hughes-Davies, D. Huntsman, M. Ruas, F. Fuks, J. Bye, and S.F. Chin EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer Cell 115 2003 523 535